公开(公告)号：US12115204B2

公开(公告)日：2024-10-15

申请号：US17790646

申请日：2021-01-05

申请人： NANTONG UNIVERSITY

发明人： Xiaosong Gu ,  Chunkang Tang ,  Fei Ding ,  Xiaoming Yang ,  Qiong Cheng ,  Hualin Sun ,  Lai Xu

IPC分类号： A61K36/481 ,  A61K35/583 ,  A61K36/076 ,  A61K36/21 ,  A61K36/232 ,  A61K36/284 ,  A61K36/286 ,  A61K36/64 ,  A61K36/725 ,  A61K36/815

CPC分类号： A61K36/481 ,  A61K35/583 ,  A61K36/076 ,  A61K36/21 ,  A61K36/232 ,  A61K36/284 ,  A61K36/286 ,  A61K36/64 ,  A61K36/725 ,  A61K36/815 ,  A61K2236/13 ,  A61K2236/331 ,  A61K2236/51

摘要： Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix, 10-20 parts of Rehmaimiae Radix praeparata, 10-20 parts of Actyranthes bidentata, 6-15 parts of Jujubae fructus, 6-15 parts of Lycii fructus, 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae smensis radix, 3-9 parts of Carthami flos, 6-15 parts of Poria, 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys. The compound preparation can be used for preparing drugs to treat nerve damage diseases, and can be prepared into oral liquids, granules, dissolved granules and tablets.